[Differential use of glucagon in acute period of myocardial infarct].
The work demonstrates the efficacy of glucagon in acute myocardial infarction and its complications, particularly in bradycardia, hypotension, disorders of cardiac rhythm and conduction, cardiogenic shock, cardiac insufficiency in complete atrioventricular heart block and recurrent forms of ventricular fibrillation. A differential approach and dynamic control over the effect of the drug on the values of hemodynamics, respiration, and metabolism are necessary under the conditions of units of intensive therapy and cardioresuscitation.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000818:Animals; D007611:Aprotinin / Q000378:metabolism; D004285:Dogs; D004837:Epinephrine / Q000378:metabolism; D004950:Esterases / Q000378:metabolism; D005934:Glucagon / Q000008:administration & dosage / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007263:Infusions, Parenteral; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D009638:Norepinephrine / Q000378:metabolism; D011288:Prekallikrein / Q000378:metabolism; D012119:Respiration / Q000187:drug effects
D005934:Glucagon; D011288:Prekallikrein; D007611:Aprotinin; D004950:Esterases; D009638:Norepinephrine; D004837:Epinephrine
Differentsirovannoe primenenie gliukagona v ostrom periode infarkta miokarda.